Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lillicrap

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Clinical Genetics|March 13, 2003
Absence of overt iron overload in two individuals compound heterozygotes for a 22 base pair deletion of exon 2 and the C282Y missense mutation of the HFE geneS M Kinkely, B D Brown, A T Lyng, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 22, 2012
von Willebrand's disease: a report from a meeting in the Åland islandsE Berntorp, I Peake, U Budde, et al.
Blood|April 11, 2022
Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia AP Batty, A M Mo, D Hurlbut, et al.
Human Gene Therapy|August 14, 1999
In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac miceA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Biology|January 21, 2022
Interlaboratory Validation of Toxicity Testing Using the Duckweed <i>Lemna minor</i> Root-Regrowth TestJihae Park, Eun-Jin Yoo, Kisik Shin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 7, 2013
Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting reportE Berntorp, B Fuchs, M Makris, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis StudyB M Feldman, M Pai, G E Rivard, et al.
Thrombosis and Haemostasis|April 1, 2000
Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia AD H Lee, I R Walker, J Teitel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 2, 2018
The Jamaican Haemophilia Registry: Describing the burden of diseaseG Wharfe, L Buchner-Daley, T Gibson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2014
Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levelsA D Shapiro, M V Ragni, R Kulkarni, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Clinical Genetics|March 13, 2003
Absence of overt iron overload in two individuals compound heterozygotes for a 22 base pair deletion of exon 2 and the C282Y missense mutation of the HFE geneS M Kinkely, B D Brown, A T Lyng, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 22, 2012
von Willebrand's disease: a report from a meeting in the Åland islandsE Berntorp, I Peake, U Budde, et al.
Blood|April 11, 2022
Long-term follow-up of liver-directed, adeno-associated vector-mediated gene therapy in the canine model of hemophilia AP Batty, A M Mo, D Hurlbut, et al.
Human Gene Therapy|August 14, 1999
In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac miceA M Gallo-Penn, P S Shirley, J L Andrews, et al.
Biology|January 21, 2022
Interlaboratory Validation of Toxicity Testing Using the Duckweed <i>Lemna minor</i> Root-Regrowth TestJihae Park, Eun-Jin Yoo, Kisik Shin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 7, 2013
Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting reportE Berntorp, B Fuchs, M Makris, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis StudyB M Feldman, M Pai, G E Rivard, et al.
Thrombosis and Haemostasis|April 1, 2000
Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia AD H Lee, I R Walker, J Teitel, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 2, 2018
The Jamaican Haemophilia Registry: Describing the burden of diseaseG Wharfe, L Buchner-Daley, T Gibson, et al.
Journal of Thrombosis and Haemostasis : JTH|September 9, 2014
Recombinant factor VIII Fc fusion protein: extended-interval dosing maintains low bleeding rates and correlates with von Willebrand factor levelsA D Shapiro, M V Ragni, R Kulkarni, et al.
Pageof 14